Skip to main content
. 2016 Jul 26;12(12):3029–3035. doi: 10.1080/21645515.2016.1214348

Table 3.

Long-term outcomes of DC vaccination estimated by interviewing the patients with herpes labialis followed for over a year.

Questions Patient number (n, %), who gave positive answer
1. Do you notice any specific health improvement after therapy  
– decrease in recurrences 7 (87.5%)
– shortening of recurrence duration 8 (100%)
– diminishing of affected areas 7 (87.5%)
2. Do you notice any general health improvement after treatment 6 (75%)
3. Did you experience any worsening in your condition (increase in recurrent infection, aggravation of chronic diseases) 0 (0%)
4. Do you have no regrets for taking part in the trial 8 (100%)